Coupling intraoperative bioprinting and surgical micropuncture for synergistic scaffold vascularization
- PMID: 40974746
- PMCID: PMC12477320
- DOI: 10.1016/j.biomaterials.2025.123711
Coupling intraoperative bioprinting and surgical micropuncture for synergistic scaffold vascularization
Abstract
Intraoperative bioprinting (IOB) is an advanced approach enabling the reconstruction of tissue defects by precisely bioprinting biologics under surgical settings. However, IOB has limited translational potential in its current form secondary to difficulty in establishing a rapidly functional, anastomosed vascular network. Micropuncture (MP) is an innovative microsurgical approach that overcomes this obstacle by creating targeted perforations in the host macrovasculature to stimulate angiogenesis, thereby facilitating microvascular ingrowth into adjacent bioprinted constructs. This study presents the first attempt of MP-induced vascularization of intraoperatively bioprinted constructs (10 mm × 15 mm × 3 mm). After precise optimization of bioink and cell compositions, IOB was performed in rat hindlimbs using rat aortic endothelial cell (RAOEC)-laden bioink to synergistically promote vascularization in conjugation with MP. The combination of MP and RAOECs demonstrated the highest values across all parameters such as a 1.8-fold vessel density increase, 2-fold increase in vessel length, a 2.5-fold increase in PECAM-1 expression, and a 4.2-fold increase in F4/80 expression on Day 40 compared to the bioink-only group. Additionally, perfusion was observed in bioprinted constructs, confirming functional microvascular anastomoses to the host. Taken together, the present study proposes an advanced pre-clinical strategy that integrates IOB for customized bioprinted platforms with MP to rapidly achieve effective in-situ vascularization.
Keywords: Endothelial cells; Intraoperative bioprinting; Micropuncture; Surgery; Vascularization.
Copyright © 2025 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dino Ravnic reports financial support was provided by National Institutes of Health. Ibrahim Ozbolat reports financial support was provided by National Institutes of Health. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
-
- Statistics P, American Society of Plastic Surgeons. 2018 Plastic Surgery Statistics Report, Plastic Surgery 25 (2017).
-
- Dantzer E, Braye FM, Reconstructive surgery using an artificial dermis (Integra): results with 39 grafts, Br. J. Plastic Surg. 54 (2001) 659–664. 10.1054/bjps.2001.3684. - DOI
-
- Diehm YF, Fischer S, Gazyakan E, Hundeshagen G, Kotsougiani-Fischer D, Falkner F, Kneser U, Hirche C, Negative pressure wound therapy as an accelerator and stabilizer for incorporation of artificial dermal skin substitutes–a retrospective, non-blinded, and non-randomized comparative study, J. Plastic Reconst. Aesthet. Surg. 74 (2021) 357–363. 10.1016/j.bjps.2020.08.041. - DOI
-
- Kreimendahl F, Köpf M, Thiebes AL, Duarte Campos DF, Blaeser A, Schmitz-Rode T, Apel C, Jockenhoevel S, Fischer H, Three-dimensional printing and angiogenesis: tailored agarose-type I collagen blends comprise three-dimensional printability and angiogenesis potential for tissue-engineered substitutes, Tissue Eng. Part C Methods 23 (2017) 604–615. 10.1089/ten.tec.2017.0234. - DOI - PubMed
-
- Bourget J-M, Kérourédan O, Medina M, Rémy M, Thébaud NB, Bareille R, Chassande O, Amédée J, Catros S, Devillard R, Patterning of endothelial cells and mesenchymal stem cells by laser-assisted bioprinting to study cell migration, Biomed. Res. Int. 2016 (2016) 3569843. 10.1155/2016/3569843. - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
